BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 8633809)

  • 1. Intratumoral administration of carboplatin for treatment of squamous cell carcinomas of the nasal plane in cats.
    Théon AP; VanVechten MK; Madewell BR
    Am J Vet Res; 1996 Feb; 57(2):205-10. PubMed ID: 8633809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratumoral chemotherapy with cisplatin in oily emulsion in horses.
    Théon AP; Pascoe JR; Carlson GP; Krag DN
    J Am Vet Med Assoc; 1993 Jan; 202(2):261-7. PubMed ID: 8428832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative intratumoral administration of cisplatin for treatment of cutaneous tumors in equidae.
    Théon AP; Pascoe JR; Meagher DM
    J Am Vet Med Assoc; 1994 Oct; 205(8):1170-6. PubMed ID: 7890578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of intratumoral administration of cisplatin versus bleomycin for treatment of periocular squamous cell carcinomas in horses.
    Théon AP; Pascoe JR; Madigan JE; Carlson G; Metzger L
    Am J Vet Res; 1997 Apr; 58(4):431-6. PubMed ID: 9099393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of strontium Sr 90 for the treatment of superficial squamous cell carcinoma of the nasal planum in cats: 49 cases (1990-2006).
    Hammond GM; Gordon IK; Theon AP; Kent MS
    J Am Vet Med Assoc; 2007 Sep; 231(5):736-41. PubMed ID: 17764434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors associated with radiotherapy of squamous cell carcinoma of the nasal plane in cats.
    Théon AP; Madewell BR; Shearn VI; Moulton JE
    J Am Vet Med Assoc; 1995 Apr; 206(7):991-6. PubMed ID: 7768722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photodynamic therapy for nasal and aural squamous cell carcinoma in cats.
    Peaston AE; Leach MW; Higgins RJ
    J Am Vet Med Assoc; 1993 Apr; 202(8):1261-5. PubMed ID: 8496082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypofractionated radiation therapy for the treatment of malignant melanoma and squamous cell carcinoma in dogs and cats].
    Kinzel S; Hein S; Stopinski T; Koch J; Buecker A; Treusacher HP; Schmachtenberg A; Jansen T; Eble M; Küpper W
    Berl Munch Tierarztl Wochenschr; 2003; 116(3-4):134-8. PubMed ID: 12680280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of perioperative versus postoperative intratumoral administration of cisplatin for treatment of cutaneous sarcoids and squamous cell carcinomas in horses.
    Théon AP; Pascoe JR; Galuppo LD; Fisher PE; Griffey SM; Madigan JE
    J Am Vet Med Assoc; 1999 Dec; 215(11):1655-60. PubMed ID: 14567430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematologic and systemic toxicoses associated with carboplatin administration in cats.
    Hahn KA; McEntee MF; Daniel GB; Legendre AM; Nolan ML
    Am J Vet Res; 1997 Jun; 58(6):677-9. PubMed ID: 9185979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative simultaneous cisplatin- or carboplatin-based chemotherapy and radiotherapy for squamous cell carcinoma of the oral cavity.
    Kirita T; Ohgi K; Tsuyuki M; Kamikaido N; Yamamoto K; Sugimura M
    J Surg Oncol; 1996 Dec; 63(4):240-8. PubMed ID: 8982368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer.
    Haraf DJ; Rosen FR; Stenson K; Argiris A; Mittal BB; Witt ME; Brockstein BE; List MA; Portugal L; Pelzer H; Weichselbaum RR; Vokes EE
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5936-43. PubMed ID: 14676118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NTP Toxicology and Carcinogenesis of 1,2,3-Trichloropropane (CAS No. 96-18-4) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Aug; 384():1-348. PubMed ID: 12692652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-arterial infusion chemotherapy using cisplatin with radiotherapy for Stage III squamous cell carcinoma of the cervix.
    Kaneyasu Y; Nagai N; Nagata Y; Hashimoto Y; Yuki S; Murakami Y; Kenjo M; Kakizawa H; Toyota N; Fujiwara H; Kudo Y; Ito K
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):369-77. PubMed ID: 19735865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT).
    Suntharalingam M; Jaboin J; Taylor R; Wolf J; Banglore M; Van Echo D; Ord R
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):2-7. PubMed ID: 15726515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combined radiotherapy with cis- or carboplatin in advanced head and neck tumors].
    Zamboglou N; Pape H; Schnabel T; Wurm R; Bannach B; Fürst G; Schmitt G
    Strahlenther Onkol; 1989 Sep; 165(9):647-51. PubMed ID: 2678546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct intratumoral chemotherapy with carboplatin and epinephrine in a recurrent cervical chordoma: case report.
    Guiu S; Guiu B; Feutray S; Chauffert B
    Neurosurgery; 2009 Sep; 65(3):E629-30; discussion E630. PubMed ID: 19687674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck.
    Shin DM; Glisson BS; Khuri FR; Lippman SM; Ginsberg L; Diaz E; Papadimitrakopoulou V; Feng L; Francisco M; Garden A; Kies MS; Myers J; Clayman G; Hong WK
    Cancer; 2002 Jul; 95(2):322-30. PubMed ID: 12124833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A combination of low-dose carboplatin (CBDCA) and radiation therapy in head and neck cancer patients--response and hematologenic toxicity].
    Watanabe N; Kaneko T; Fujitani S; Umeyama M; Nomura Y; Zusho H; Yamada Y; Nanba G; Asahina N; Sugio Y; Okamoto Y; Daida T; Tokumaru T
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):101-6. PubMed ID: 9987505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.